Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumors (Q37140621)
Jump to navigation
Jump to search
scientific article published on 04 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumors |
scientific article published on 04 March 2009 |
Statements
1 reference
Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumors (English)
1 reference
Noboru Yamamoto
1 reference
Yasuhide Yamada
1 reference
Yutaka Fujiwara
1 reference
Kazuhiko Yamada
1 reference
Yasuhito Fujisaka
1 reference
Toshio Shimizu
1 reference
Tomohide Tamura
1 reference
4 March 2009
1 reference
1 reference
260-266
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference